三(2-吡啶基)膦
|
T282257-100mg
|
≥98% |
26437-48-9 |
100mg
|
¥ 572.9
|
期货,请咨询 |
阿拉丁 |
三辛基膦硒化物
|
T282181-5g
|
≥80% |
20612-73-1 |
5g
|
¥ 499.9
|
期货,请咨询 |
阿拉丁 |
三(异丁基氨基乙基)胺
|
T281624-1g
|
≥97% |
331465-73-7 |
1g
|
¥ 1539.9
|
期货,请咨询 |
阿拉丁 |
2-[(三氟甲基)硫基]-1,1-二氧化物-1,2-苯并异噻唑-3(2H)-酮
|
T281609-100mg
|
≥97% |
1647073-46-8 |
100mg
|
¥ 88.9
|
现货 |
阿拉丁 |
内-3-Boc-氨基托烷
|
T173362-250mg
|
≥97% |
132234-69-6 |
250mg
|
¥ 759.9
|
现货 |
阿拉丁 |
内-3-Boc-氨基托烷
|
T173362-100mg
|
≥97% |
132234-69-6 |
100mg
|
¥ 499.9
|
现货 |
阿拉丁 |
1-[2-(三氟甲基)苯基]咪唑
|
T162843-5g
|
Moligand™, ≥98% |
25371-96-4 |
5g
|
¥ 1550.9
|
期货,请咨询 |
阿拉丁 |
1-[2-(三氟甲基)苯基]咪唑
|
T162843-250mg
|
Moligand™, ≥98% |
25371-96-4 |
250mg
|
¥ 186.9
|
期货,请咨询 |
阿拉丁 |
1-(2-噻唑偶氮)-2-萘酚
|
T162491-250mg
|
≥99% |
1147-56-4 |
250mg
|
¥ 139.9
|
现货 |
阿拉丁 |
三苯基二氯化铋
|
T162395-250mg
|
≥98% |
594-30-9 |
250mg
|
¥ 185.9
|
期货,请咨询 |
阿拉丁 |
1,3,5-三噻烷
|
T162310-5g
|
≥97% |
291-21-4 |
5g
|
¥ 229.9
|
现货 |
阿拉丁 |
2-(5-叔丁基-2-羟苯基)苯并三唑
|
T162245-100g
|
≥98% |
3147-76-0 |
100g
|
¥ 1083.9
|
现货 |
阿拉丁 |
2,3-噻吩二甲酸酐
|
T162186-250mg
|
≥98% |
6007-83-6 |
250mg
|
¥ 298.9
|
期货,请咨询 |
阿拉丁 |
11,11,12,12-四氰基萘-2,6-醌二甲烷
|
T161954-25mg
|
≥95% |
6251-01-0 |
25mg
|
¥ 539.9
|
期货,请咨询 |
阿拉丁 |
叔丁基甲硫醚
|
T161885-100ml
|
≥98% |
6163-64-0 |
100ml
|
¥ 2099.9
|
期货,请咨询 |
阿拉丁 |
10-(1,1':3',1''-三联苯-5'-基)蒽-9-硼酸 (含有数量不等的酸酐)
|
T161759-250mg
|
≥97% |
1415334-59-6 |
250mg
|
¥ 749.9
|
现货 |
阿拉丁 |
2,2,2-三氟-1-(9-蒽基)乙醇
|
T161666-5g
|
≥97% |
65487-67-4 |
5g
|
¥ 2690.9
|
期货,请咨询 |
阿拉丁 |
(+)-反-1,2-环己烷二甲酸酐
|
T161606-250mg
|
≥98%(GC) |
71749-03-6 |
250mg
|
¥ 416.9
|
现货 |
阿拉丁 |
4-叔丁基环己胺
|
T161455-100ml
|
≥98%, cis- and trans- mixture |
5400-88-4 |
100ml
|
¥ 2490.9
|
期货,请咨询 |
阿拉丁 |
总碱度溶液标准物质
|
T117594-50ml
|
1000ug/mL in water |
N/A |
50ml
|
¥ 111.9
|
现货 |
阿拉丁 |
硅微粉
|
S616503-500g
|
|
N/A |
500g
|
¥ 39.9
|
现货 |
阿拉丁 |
硅微粉
|
S616503-2.5kg
|
|
N/A |
2.5kg
|
¥ 119.9
|
现货 |
阿拉丁 |
高碘酸钠
|
S616472-500g
|
≥99.5% |
7790-28-5 |
500g
|
¥ 899.9
|
现货 |
阿拉丁 |
高碘酸钠
|
S616472-2.5kg
|
≥99.5% |
7790-28-5 |
2.5kg
|
¥ 3500.9
|
现货 |
阿拉丁 |